• 33

    Backer(s)
  • $ 7,110

    pledged of $ 7,000 goal
  • 945

    days ago
  • Funded!

    This project was successfully funded.

  • This project was successfully funded on 2014-10-24

About our project



The Problem of Breast Cancer:

One-in-eight women in the U.S. will be diagnosed with breast cancer in their lifetime, making it the most common cancer for American women. If detected early, many women may forgo a mastectomy (entire breast removal) for Breast-Conserving Therapy (BCT), which requires both a lumpectomy (tumor removal) and radiation therapy. However, at least one-in-five of these patients require a second surgery after the lumpectomy because of residual cancer. These women must still undergo 5-7 weeks of daily radiation, which is dangerous and expensive.

Helping Women with Early Stage Breast Cancer:

Innoblative’s mission is to provide women with early stage breast cancer better options that will support their emotional and physical wellbeing. We have designed a novel ablation probe for use during a lumpectomy (tumor removal from the breast), which is inserted into the breast cavity after tumor removal and delivers heat (hyperthermia) using safe radiofrequency electrical signals to destroy residual cancer. We believe this will limit the need for reoperation and eliminate the need for radiation treatment in most patients. As a result, patients would no longer have to go through 5-7 weeks of daily radiation sessions and suffer short and long-term side effects.

The Innoblative Team:

Two surgeons, Dr. David Mahvi, chief of Surgical Oncology at Northwestern Memorial Hospital, and Dr. Dan McCarthy, surgical resident at Northwestern Memorial Hospital, envisioned the idea during their operations, noticing that early stage breast cancer was sorely lacking a safe, non-disfiguring option. Innoblative has grown into an interdisciplinary team of dedicated individuals with backgrounds in biomedical and electrical engineering, law, business, medicine, and innovation. Our team is dedicated to making cancer treatment more simple and cost effective for patients and the healthcare system:

Tyler R. Wanke, MD, MBA, MEM* – Chief Executive Officer
Jason M. Sandler, JD-MBA* – Chief Operating Officer
Adam E. Piotrowski, MS – Chief Technology Officer
Daniel P. McCarthy, MD, MBA, MEM – VP of Clinical Affairs
Curtis Wang, PhD student – VP of Research and Development
Kate Yeskey, MBA* – VP of Program Management
Victor Simoes, MBA* – VP of Finance
Brian J. Robillard, MS – Engineering Consultant
David M. Mahvi, MD – Chief, Division of Surgery-Surgical Oncology, Northwestern Memorial Hospital
*Candidate

Your Funding Will Help Us Help Patients:

We have tested our technology in computational models and tissue models. We are now seeking at least $15,000 to engage Insight Product Development to co-develop the device for an animal trial.

Engage With Us!
Visit our website
Follow us on Facebook
Follow us on twitter @innoblative
Email us

Rewards

For $ 20 or more

12 Backer(s)


Letter of thanks from team Innoblative

For $ 75 or more

7 Backer(s)


Branded “swag” (e.g. hat, t-shirt, tote bag) and letter of thanks from team Innoblative

For $ 150 or more

1 Backer(s)


Several branded “swag” items (e.g. hat, t-shirt, tote bag) and a letter of thanks from team Innoblative

For $ 500 or more

0 Backer(s)


Breast cancer awareness gift package, and all of the above rewards

For $ 1500 or more

1 Backer(s)


Innoblative puzzle piece customized for you donation, to be displayed on our wall of heroes at Insight Product Development, and all of the above rewards

For $ 5000 or more

0 Backer(s)


Special invitation to meet team Innoblative at the Health Tech event in Chicago on October 23rd, and all of the above rewards

For $ 10000 or more

0 Backer(s)


VIP dinner hosted by team Innoblative in Chicago, special invitation to future investment opportunities, and all of the above rewards

    No updates found .

    No comments found .

Login to post your comment!
Click here to Login